Perrigo (PRGO) Total Current Liabilities (2013 - 2026)
Perrigo (PRGO) posted quarterly Total Current Liabilities of $997.6 million for Q1 2026, down 7.1% year-over-year from $1.1 billion in Q1 2025, and down 1.51% quarter-over-quarter from $1.0 billion in Q4 2025.
Perrigo (PRGO) Total Current Liabilities (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Total Current Liabilities for 14 consecutive years, with $997.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 7.1% year-over-year to $997.6 million; the TTM figure through Mar 2026 stood at $997.6 million (down 7.1% YoY), while the FY2025 annual figure was $1.0 billion, down 3.0% from the prior year.
- Total Current Liabilities declined to $997.6 million in Q1 2026 per PRGO's latest filing, from $1.0 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.6 billion in Q4 2023 and bottomed at $981.3 million in Q2 2022.
- Historically, Total Current Liabilities has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2025.
- Annual changes were most pronounced in 2022 — Total Current Liabilities sank 49.35% — and 2024, when it surged 43.84%.
- Perrigo's Total Current Liabilities stood at $1.1 billion in 2022, then jumped by 42.45% to $1.6 billion in 2023, then sank by 34.17% to $1.0 billion in 2024, then retreated by 3.0% to $1.0 billion in 2025, then slipped by 1.51% to $997.6 million in 2026.
- Business Quant data shows PRGO's Total Current Liabilities at $997.6 million in Q1 2026, $1.0 billion in Q4 2025, and $1.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.79 Bn |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn | 1.05 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 1.05 Bn |
| Mar 28, 2026 | 997.60 Mn |
| Dec 31, 2025 | 1.01 Bn |
| Sep 27, 2025 | 1.15 Bn |
| Jun 28, 2025 | 1.13 Bn |
| Mar 29, 2025 | 1.07 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 28, 2024 | 1.45 Bn |
| Jun 29, 2024 | 1.49 Bn |
| Mar 30, 2024 | 1.55 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.01 Bn |
| Jul 1, 2023 | 1.06 Bn |
| Apr 1, 2023 | 1.09 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Oct 1, 2022 | 1.02 Bn |
| Jul 2, 2022 | 1.01 Bn |
| Apr 2, 2022 | 981.30 Mn |
| Dec 31, 2021 | 1.59 Bn |
| Oct 2, 2021 | 2.00 Bn |